Cargando…
Targeting type 2 immunity and the future of food allergy treatment
IgE-mediated food allergy affects 6–8% of the population in the United States. Type 2 immune responses are central to the pathogenesis of food allergy, but type 2 CD4(+) T cell responses have been found to be heterogeneous in food allergy suggesting a division of labor between Tfh13 and peTH2 cells...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Rockefeller University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997511/ https://www.ncbi.nlm.nih.gov/pubmed/36880703 http://dx.doi.org/10.1084/jem.20221104 |